RxDoctor Payments Data

John Fallon

Internal Medicine · Boston, MANPI 1609816883

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,715,615 of the $1,792,373 with a category attached, or 95.7%. Insulet Corporation accounts for 93.6% of it on its own, with 2 other manufacturers making up the rest. Among internal medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,792,373in general payments, 2019–2025

Across 21 payments — averaging $85,351 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insulet Corporation$1.7M
  • AMAG Pharmaceuticals, Inc.$113K
  • Renovia Inc$815

What the payments were for

  • Consulting fees$75,5114%
  • Speaking & faculty fees$1,715,61596%
  • Travel & lodging$9180%
  • Food & beverage$3290%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Insulet Corporation9$1,678,547
AMAG Pharmaceuticals, Inc.8$113,011
Renovia Inc4$815

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,792,373 in reported general payments places this provider in the 95th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts →

Other internal medicine in Boston

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →